CVRx (CVRX) 10-Q2024 Q3 Quarterly report

Filed: 1 Nov 24, 6:30am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: alternatively, American, back, Cardiology, Category, College, CPT, creation, Editorial, facilitate, goal, inpatient, moving, Neurostimulator, Society, streamline, Surgery, work

Removed: assignment, endpoint, inclusion, member, mortality, study

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated CVRX transcripts

CVRX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification of CEO Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of CVRx, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2024 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, the undersigned, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

(1)

The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2024




	By:	/s/ Kevin Hykes
	Name:	Kevin Hykes
	Title:	President and Chief Executive Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.